01244.HK
3D Medicines Inc.
HKSE · Healthcare · Biotechnology · CN
HKD 2.47
+9.29%Margins
Gross margin
88.5%
EBITDA margin
-47.9%
EBIT margin
-24.2%
Net margin
-48.5%
FCF margin
-33.1%
-33.1%
Return on equity
-18.5%
Return on assets
-12.4%
Return on invested capital
0.38x
Asset turnover
-HKD 138.6M
Cash from operations
HKD 1.88
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026